Evidence map›Paper›PMID 33979399›Full record

ArticlePloS one2021

Overall survival based on oncologist density in the United States: A retrospective cohort study.

Sudeep K Siddappa Malleshappa, Smith Giri, Smit Patel, Tapan Mehta, Leonard Appleman, Scott F Huntington, Vida Passero, Rahul A Parikh, Kathan D Mehta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Sudeep K Siddappa MalleshappaDivision of Hematology-Oncology, Department of Medicine, UMass-Baystate Medical Center, Springfield, MA, United States of America.
Smith GiriDivision of Hematology-Oncology, Department of Medicine, University of Birmingham, Birmingham, AL, United States of America.
Smit PatelDepartment of Neurology, University of Connecticut, Farmington, CT, United States of America.
Tapan MehtaDepartment of Neurology, University of Minnesota, Minneapolis, MN, United States of America.
Leonard ApplemanDivision of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America.
Scott F HuntingtonDivision of Hematology-Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT, United States of America.
Vida PasseroDivision of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America.
Rahul A ParikhDivision of Hematology-Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS, United States of America.
Kathan D MehtaDivision of Hematology-Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS, United States of America.ORCID 0000-0002-0428-3074
University of Kansas Medical Center · USUniversity of Pittsburgh Medical Center · USBaystate Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Connecticut · USUniversity of Minnesota · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Medically underserved areas (MUA) or health professional shortage areas (HPSA) designations are based on primary care health services availability. These designations are used in recruiting international medical graduates (IMGs) trained in primary care or subspecialty (e.g., oncology) to areas of need. Whether the MUA/HPSA designation correlates with Oncologist Density (OD) and supports IMG oncologists' recruitment to areas of need is unknown. We evaluated the concordance of OD with the designation of MUAs/HPSAs and evaluated the impact of OD and MUA/HPSA status on overall survival. We conducted a retrospective cohort study of patients diagnosed with hematological malignancies or metastatic solid tumors in 2011 from the Surveillance Epidemiology and End Results (SEER) database. SEER was linked to the American Medical Association Masterfile to calculate OD, defined as the number of oncologists per 100,000 population at the county level. We calculated the proportion of counties with MUA or HPSA designation for each OD category. Overall survival was estimated using the Kaplan-Meier method and compared between the OD category using a log-rank test. We identified 68,699 adult patients with hematologic malignancies or metastatic solid cancers in 609 counties. The proportion of MUA/HPSA designation was similar across counties categorized by OD (93.2%, 95.4%, 90.3%, and 91.7% in counties with <2.9, 2.9-6.5, 6.5-8.4 and >8.4 oncologists per 100K population, p = 0.7). Patients' median survival in counties with the lowest OD was significantly lower compared to counties with the highest OD (8 vs. 11 months, p<0.0001). The difference remained statistically significant in multivariate and subgroup analysis. MUA/HPSA status was not associated with survival (HR 1.03, 95%CI 0.97-1.09, p = 0.3). MUA/HPSA designation based on primary care services is not concordant with OD. Patients in counties with lower OD correlated with inferior survival. Federal programs designed to recruit physicians in high-need areas should consider the availability of health care services beyond primary care.

Indexed as

Cohort StudiesData ManagementHealth Services AccessibilityHumansMedically Underserved AreaMortalityNeoplasmsOncologistsPhysiciansPopulation DensityPrimary Health CareRetrospective StudiesUnited States

Identifiers

PMID33979399
PMCPMC8115849
OpenAlexW3162000924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.